<http://schema.org/description>
"Elan Issues Response Document Further Detailing Inadequacy of Royalty Pharma&amp;#039;s Revised Offer   Royalty Pharma&amp;#039;s Revised Offer Grossly Undervalues Elan&amp;#039;s Tysabri and Cash Value"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2013/06/03/elan-issues-response-document-further-detailing-in/20596199/>